July 23, 2014 2:11 AM ET

Pharmaceuticals

Company Overview of Aspen Pharma Indústria Farmacêutica Ltda.

Company Overview

Aspen Pharma Indústria Farmacêutica Ltda. operates as a pharmaceutical company. It owns Melxi, a phytotherapic syrup and is composed by honey and pineapple pulp and contains carbohydrates with pharmacological activities. The company was formerly known as Cellofarm Ltda. The company is based in Carpina-Serra, Brazil. Aspen Pharma Indústria Farmacêutica Ltda. operates as a subsidiary of Aspen Pharmacare Holdings Limited.

Rodovia BR-101, KM 271

Contorno De Vitoria

S/N, Tims-Sector Industrial-Q.10-M.03

Carpina-Serra, ES 29160-970

Brazil

Phone:

55 21 3544 6956

Fax:

55 21 3544 6958

Key Executives for Aspen Pharma Indústria Farmacêutica Ltda.

Chief Executive Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Medley Indústria Farmacêutica Ltda. Americas
EMS S/A Americas
Grupo RPH Americas
Laboratorios Wyeth-Whitehall Ltda. Americas
Germed Farmacêutica Ltda. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aspen Pharma Indústria Farmacêutica Ltda., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.